Baxter International Inc. (Deerfield, IL) announced new data showing use of Baxter’s Sharesource remote patient management (telehealth) platform for automated peritoneal dialysis (APD) therapy performed in Colombia was associated with a 56% reduction in technique failure.
In a separate study conducted in Canada, data show 74% of patients, who received expanded hemodialysis (HDx) therapy enabled by Theranova, self-reported an improved quality of life through better energy, sleep, appetite and/or reduced pain.